Intranasal administration of PTH(1-34) for the treatment of osteoporosis - equivalence to subcutaneous injection at the neck of femur in the Food and Drug Administration (FDA) mandated preclinical model (Oral Presentation - Pearson). (2015)

First Author: Williams AJ
Attributed to:  PTH nasal delivery for the treatment of osteoporosis - TSB NINTTO funded by EPSRC

Abstract

No abstract provided

Bibliographic Information

Publication URI: http://abstracts.ects-ibms2015.org/ectsibms/0001/ectsibms0001p341.htm

Type: Conference/Paper/Proceeding/Abstract